Target- |
MechanismAmino acid replacements |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1982 |
|
MechanismHPRT1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date11 Sep 1953 |
100 Clinical Results associated with Shaanxi Hantang Pharmaceutical Co Ltd.
0 Patents (Medical) associated with Shaanxi Hantang Pharmaceutical Co Ltd.
100 Deals associated with Shaanxi Hantang Pharmaceutical Co Ltd.
100 Translational Medicine associated with Shaanxi Hantang Pharmaceutical Co Ltd.